PyroDex

Automated Monocyte Activation Testing Technology for Microbial Detection
PyroDex’s full commitment to microbial detection helps you save time and money.
Our service focuses entirely on testing injectable and implantable therapeutic products for microbial contamination, using an automated MAT technology that’s:

Fast
Comprehensive
Reliable
Quantifiable
Vision
Healthcare for all at affordable costs.

We envision that PyroDex detection systems will become the method of choice to rapidly and reliably test the safety of therapeutic products in the biopharmaceutical industry. To demonstrate the superiority of the technology, and its importance to protect public health and investment, we intend 1) to partner with manufacturers and clinicians to provide a focused service of rapid safety tests with a short turnaround; and 2) to provide the necessary tools to support regulatory decisions regarding therapeutic product safety.

Mission
To help medical drug and device makers increase clinical trial success rates and accelerate commercialization, through a focused, rapid and, comprehensive pyrogenic contaminant detection service using technologies that do not rely on animals or animal products.

Core Beliefs
1) That more comprehensive testing to detect possible contaminants will result in safer drugs and medical devices for clinical trials, better and more successful treatment, more lives saved, and better return on investment; and 2) that many clinical trial failures are due, not to the inefficacy of medical drugs or engineering design flaws, but to contaminants that current safety testing methods do not detect.